Related Experiment Video
Updated: Jun 13, 2025

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Primary tuberculous pyogenic ventriculitis in an immunocompetent patient: A case report
Fresnel Lutèce Ontsi Obame1, Saad Moussa Elmi1, Yao Christian Hugues Dokponou1
1Department of Neurosurgery, Mohammed V Military Training Hospital, Mohammed V Faculty of Medicine and Pharmacy, Rabat, Morocco.
Tuberculous pyogenic ventriculitis, a rare but severe central nervous system tuberculosis complication, can be successfully treated. Early diagnosis and intervention are crucial for managing this devastating condition in immunocompetent individuals.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Tuberculosis (TB) affecting the central nervous system (CNS) is common.
- Tuberculous pyogenic ventriculitis is a rare and severe manifestation of intracranial TB.
- Untreated tuberculous pyogenic ventriculitis can be devastating, even in immunocompetent patients.
Observation:
- A case of a 43-year-old male patient with tuberculous pyogenic ventriculitis is presented.
- The patient presented with symptoms including meningeal syndrome and loss of consciousness.
- Successful treatment outcomes were achieved for this patient.
Findings:
- Tuberculous pyogenic ventriculitis is an uncommon form of intraventricular tuberculosis.
- Diagnosis relies heavily on biological markers, despite advancements in neuroimaging.
- The case highlights the possibility of successful therapeutic interventions.
Implications:
- This case underscores the importance of considering rare tuberculous infections of the CNS.
- It emphasizes the need for timely and accurate diagnosis, particularly biological confirmation.
- Successful treatment suggests that even severe presentations of tuberculous pyogenic ventriculitis can be managed effectively.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

